Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Position Increased by Jones Financial Companies Lllp

Jones Financial Companies Lllp boosted its holdings in shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) by 52.9% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,315 shares of the company’s stock after buying an additional 801 shares during the period. Jones Financial Companies Lllp’s holdings in Invesco Biotechnology & Genome ETF were worth $154,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of PBE. Jane Street Group LLC acquired a new position in Invesco Biotechnology & Genome ETF during the third quarter worth $295,000. HighTower Advisors LLC increased its position in Invesco Biotechnology & Genome ETF by 64.1% during the third quarter. HighTower Advisors LLC now owns 7,101 shares of the company’s stock worth $494,000 after buying an additional 2,774 shares during the last quarter. IHT Wealth Management LLC increased its position in Invesco Biotechnology & Genome ETF by 14.7% during the third quarter. IHT Wealth Management LLC now owns 12,124 shares of the company’s stock worth $847,000 after buying an additional 1,550 shares during the last quarter. Howe & Rusling Inc. acquired a new position in Invesco Biotechnology & Genome ETF during the third quarter worth $31,000. Finally, Massachusetts Wealth Management grew its position in shares of Invesco Biotechnology & Genome ETF by 1.3% in the fourth quarter. Massachusetts Wealth Management now owns 18,414 shares of the company’s stock valued at $1,225,000 after purchasing an additional 230 shares during the last quarter.

Invesco Biotechnology & Genome ETF Stock Performance

Shares of NYSEARCA:PBE opened at $65.60 on Friday. The company has a market cap of $240.10 million, a P/E ratio of 22.64 and a beta of 0.80. The stock’s 50-day moving average is $67.73 and its 200-day moving average is $68.73. Invesco Biotechnology & Genome ETF has a 52-week low of $59.32 and a 52-week high of $72.84.

About Invesco Biotechnology & Genome ETF

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.